Logo image of UPR.I

UNIPHAR PLC (UPR.I) Stock Price, Forecast & Analysis

Europe - Euronext Dublin - DUB:UPR - IE00BJ5FQX74 - Common Stock

3.6 EUR
-0.1 (-2.7%)
Last: 1/16/2026, 7:00:00 PM

UPR.I Key Statistics, Chart & Performance

Key Statistics
Market Cap934.45M
Revenue(TTM)2.89B
Net Income(TTM)66.31M
Shares259.57M
Float246.33M
52 Week High4.17
52 Week Low2
Yearly Dividend0.02
Dividend Yield0.87%
EPS(TTM)0.22
PE16.36
Fwd PE14.21
Earnings (Next)02-23
IPO2019-07-17
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors
UPR.I short term performance overview.The bars show the price performance of UPR.I in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4 -6

UPR.I long term performance overview.The bars show the price performance of UPR.I in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of UPR.I is 3.6 EUR. In the past month the price increased by 2.27%. In the past year, price increased by 76.47%.

UNIPHAR PLC / UPR Daily stock chart

UPR.I Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to UPR.I. When comparing the yearly performance of all stocks, UPR.I is one of the better performing stocks in the market, outperforming 85.19% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

UPR.I Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to UPR.I. UPR.I has an excellent profitability rating, but there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UPR.I Financial Highlights

Over the last trailing twelve months UPR.I reported a non-GAAP Earnings per Share(EPS) of 0.22. The EPS increased by 16.84% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.3%
ROA 4.25%
ROE 17.78%
Debt/Equity 1.21
Chartmill High Growth Momentum
EPS Q2Q%20.99%
Sales Q2Q%8.62%
EPS 1Y (TTM)16.84%
Revenue 1Y (TTM)7.73%

UPR.I Forecast & Estimates

12 analysts have analysed UPR.I and the average price target is 4.93 EUR. This implies a price increase of 36.97% is expected in the next year compared to the current price of 3.6.

For the next year, analysts expect an EPS growth of 14.54% and a revenue growth 8.68% for UPR.I


Analysts
Analysts81.67
Price Target4.93 (36.94%)
EPS Next Y14.54%
Revenue Next Year8.68%

UPR.I Ownership

Ownership
Inst Owners48.81%
Ins Owners5.09%
Short Float %N/A
Short RatioN/A

About UPR.I

Company Profile

UPR logo image Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.

Company Info

UNIPHAR PLC

4045 Kingswood Road, Citywest Business Park

DUBLIN DUBLIN IE

Employees: 3500

UPR Company Website

UPR Investor Relations

Phone: 35314687501

UNIPHAR PLC / UPR.I FAQ

Can you describe the business of UNIPHAR PLC?

Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.


What is the stock price of UNIPHAR PLC today?

The current stock price of UPR.I is 3.6 EUR. The price decreased by -2.7% in the last trading session.


Does UPR stock pay dividends?

UNIPHAR PLC (UPR.I) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.02.


How is the ChartMill rating for UNIPHAR PLC?

UPR.I has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the valuation of UNIPHAR PLC (UPR.I) based on its PE ratio?

The PE ratio for UNIPHAR PLC (UPR.I) is 16.36. This is based on the reported non-GAAP earnings per share of 0.22 and the current share price of 3.6 EUR.


Should I buy UPR stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on UPR.I.